Congressman Brad Finstad (MN-01), member of the House Committee on Agriculture, led members of Minnesota’s Congressional Delegation in sending a letter to U.S. Department of Agriculture (USDA) Secretary Brooke Rollins regarding the significant loss Minnesota turkey growers have experienced from avian metapneumovirus (aMPV). Specifically, the letter urges USDA to recognize qualifying aMPV-related turkey mortality as eligible for assistance through the Livestock Indemnity Program (LIP), USDA’s program that pays farmers and ranchers for animal deaths or injuries above normal levels.
Avian metapneumovirus resulted in the loss of over 2.2 million birds in 2024 alone and has continued to severely impact Minnesota flocks. As the leading turkey-producing state, the spread of aMPV raises serious concerns about the impact on the poultry sector.
The letter reads:
Dear Secretary Rollins:
We write to renew and emphasize our request that the U.S. Department of Agriculture (USDA) allow turkey growers to utilize the Livestock Indemnity Program (LIP) to recover a portion of the devastating losses caused by avian metapneumovirus (aMPV). We further ask USDA to provide a process for growers to submit applications retroactively for eligible losses incurred in 2024 and 2025.
Based on the merits of turkey grower claims, veterinary expert opinions, and the program’s eligibility standards, it is unclear why the USDA has deemed aMPV as ineligible under LIP. Avian metapneumovirus is transmitted via vectors, and growers had no commercially available vaccine to protect their flocks during the years in question. Due to this, producers could not reasonably prevent these losses despite following recommended biosecurity practices and working closely with their veterinarians.
The rapid spread of aMPV hit small and independent growers especially hard, with some sustaining repeated losses before an effective vaccine became commercially available. These losses were beyond normal mortality and were caused by circumstances outside the growers’ control.
USDA’s National Appeals Division has issued decisions establishing significant administrative precedent regarding the eligibility of aMPV-related losses under LIP. These decisions recognize that aMPV can and should qualify as an eligible disease when producers provide sufficient evidence demonstrating that the disease directly caused mortality beyond normal levels. USDA should apply that reasoning consistently and fairly to similarly situated growers rather than requiring each producer to pursue a lengthy and costly individual appeal.
Source : house.gov